MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress. Sipol A, Hameister E, Xue B, Hofstetter J, et al. Blood 2022;139:1184-1197.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Sipol A, Hameister E, Xue B, Hofstetter J, et al. MondoA drives malignancy in B-ALL through enhanced adaptation to metabolic stress. Blood 2022;139:1184-1197.
PMID: 33908607